Jason T. Henry - Sarah Cannon | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-specific Transcriptome and Molecular Subtype

Vahid Bahrambeigi,Jaewon J. Lee,Vittorio Branchi,Kimal I. Rajapakshe, Zhichao Xu,Naishu Kui,Jason T. Henry,Wang Kun,Bret M. Stephens,Sarah Dhebat,Mark W. Hurd,Ryan Sun,Peng Yang,Eytan Ruppin,Wenyi Wang,Scott Kopetz,Anirban Maitra,Paola A. Guerrero

CANCER RESEARCHno. 10 (2024): 1719-1732

引用0浏览0WOS引用

Supplemental Figures 1-10 from Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype

crossref（2024）

引用0浏览0引用

Phase 1 Study of BDTX-1535, an Oral 4th Generation Covalent EGFR Inhibitor, in Patients with Recurrent Glioblastoma: Preliminary Dose Escalation Results

Patrick Y. Wen,Melissa Lynne Johnson,Jason Timothy Henry,Alex Spira,James Battiste,Iyad Alnahhas,Do-Hyun Nam,Jyoti D. Patel,William Jeffery Edenfield,Adilia Hormigo, Shinkyo Yoon,Tae Min Kim,Sudharshan Eathiraj,Julio Hajdenberg,Sergey Yurasov,Manmeet Singh Ahluwalia

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Abstract C164: A Phase 1 Dose-Escalation Study of PRT2527, a Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, in Adult Patients with Advanced Solid Tumors: an Updated Analysis

Manish R. Patel,Astrayee Basu-Mallick,Filemon Dela Cruz,Douglas Orr,Alex Spira,Guru P. Sonpavde,Pooja Ghatalia,Christine Lihou,Neelesh Sharma,Peggy Scherle, William Sun, Sri Sahasranaman,Jason T. Henry

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

Phase 1 Study of SGN-BB228, an Investigational CD228 X 4-1BB Costimulatory Antibody Anticalin Bispecific, in Patients with Advanced Melanoma and Other Solid Tumors (SGNBB228-001)

Jason Timothy Henry,Janice M. Mehnert, Erika Rudnicki,Juan Pinelli,Adil Daud

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Abstract C031: A Randomized Phase 1b Study of IGM-8444 in Combination with FOLFIRI + Bevacizumab Compared to FOLFIRI + Bevacizumab Alone in Second Line Metastatic Colorectal Cancer

Susanna V. Ulahannan,Meredith S. Pelster,Patricia LoRusso,Gerald S. Falchook,Judy Wang, Minal Barve,Jaspreet Singh Grewal,Warren Chow,Jason T. Henry,Michael Cecchini,Vivek Subbiah,Maya Leabman,Genevive Hernandez, Lijia Yao,Angus M. Sinclair,Béatrice Wang,Maya F. Kotturi,Eric W. Humke, Sean Ahern, Leslie Ennis, Melaine Caruano, Sapeck Agrawal

Molecular cancer therapeuticsno. 12_Supplement (2023): C031-C031

引用0浏览0引用

Abstract C036: A Phase 1 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients with Glioblastoma or Non-Small Cell Lung Cancer

Helena Yu,Melissa Johnson,Jason T Henry,Alex Spira,Ji-Youn Han, Minal Barve,James Battiste,Iyad Alnahhas,DoHyun Nam,Jeffrey Edenfield,Balazs Halmos,Shinkyo Yoon,Tae Min Kim,Sudharshan Eathiraj,Julio Hajdenberg,Sergey Yurasov,Manmeet Ahluwalia,Patrick Wen

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

Abstract CT017: Pan-mutant and Isoform Selective PI3Kα Inhibitor, RLY-2608, Demonstrates Selective Targeting in a First-in-human Study of PIK3CA-mutant Solid Tumor Patients, ReDiscover Trial

Andreas Varkaris,Komal Jhaveri,Cesar A. Perez,Janice S. Kim,Jason T. Henry,Vivek Subbiah,Alexander I. Spira, Lucía Sanz Gómez,Ángel Guerrero-Zotano,Kari B. Wisinski,Xiaoyan Li,Gege Tan,Ramin Samadani,Tamieka L. Hunter,Wei Guo,Alison Timm,Djuro Karanovic,Beni B. Wolf,Erika Hamilton,Alison M. Schram

Cancer researchno. 8_Supplement (2023): CT017-CT017

引用0浏览0引用

Abstract CT173: A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of PRT2527, a Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, in Adult Patients (pts) with Advanced Solid Tumors

Jason T. Henry,Douglas Orr,Atrayee Basu-Mallick,Alex Spira,Christine Lihou, Neelesh Sharma,Peggy Scherle,Rachel Chiaverelli,Manish R. Patel

Cancer Researchno. 8_Supplement (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn